Suppr超能文献

丙型肝炎病毒结构蛋白在昆虫细胞中组装成病毒样颗粒。

Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.

作者信息

Baumert T F, Ito S, Wong D T, Liang T J

机构信息

Liver Diseases Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Virol. 1998 May;72(5):3827-36. doi: 10.1128/JVI.72.5.3827-3836.1998.

Abstract

Hepatitis C virus (HCV) is a leading cause of chronic hepatitis in the world. The study of HCV has been hampered by the low level of viral particles in infected individuals, the inability to propagate efficiently the virus in cultured cells, and the lack of a convenient animal model. Due to these obstacles, neither the structure of the virus nor the prerequisites for its assembly have been clearly defined. In this report, we describe a model for the production and purification of HCV-like particles in insect cells using a recombinant baculovirus containing the cDNA of the HCV structural proteins. In insect cells, expressed HCV structural proteins assembled into enveloped viruslike particles (40 to 60 nm in diameter) in large cytoplasmic cisternae, presumably derived from the endoplasmic reticulum. Biophysical characterization of viruslike particles by CsCl and sucrose gradient centrifugation revealed biophysical properties similar to those of putative virions isolated from infected humans. The results suggested that HCV core and envelope proteins without p7 were sufficient for viral particle formation. Analysis of particle-associated nucleic acids demonstrated that HCV RNAs were selectively incorporated into the particles over non-HCV transcripts. The synthesis of HCV-like particles in insect cells may provide an important tool to determine the structural requirements for HCV particle assembly as well as to study viral genome encapsidation and virus-host interactions. The described system may also represent a potential approach toward vaccine development.

摘要

丙型肝炎病毒(HCV)是全球慢性肝炎的主要病因。HCV研究受到以下因素的阻碍:受感染个体中病毒颗粒水平较低、无法在培养细胞中高效繁殖该病毒以及缺乏便利的动物模型。由于这些障碍,病毒的结构及其组装所需条件均未得到明确界定。在本报告中,我们描述了一种利用含有HCV结构蛋白cDNA的重组杆状病毒在昆虫细胞中生产和纯化HCV样颗粒的模型。在昆虫细胞中,表达的HCV结构蛋白在大的细胞质池中组装成包膜病毒样颗粒(直径40至60纳米),这些池大概源自内质网。通过氯化铯和蔗糖梯度离心对病毒样颗粒进行生物物理表征,结果显示其生物物理特性与从受感染人类中分离出的假定病毒粒子相似。结果表明,不含p7的HCV核心蛋白和包膜蛋白足以形成病毒颗粒。对颗粒相关核酸的分析表明,与非HCV转录本相比,HCV RNA被选择性地整合到颗粒中。在昆虫细胞中合成HCV样颗粒可能为确定HCV颗粒组装的结构要求以及研究病毒基因组包装和病毒-宿主相互作用提供重要工具。所描述的系统也可能代表一种潜在的疫苗开发方法。

相似文献

1
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.
J Virol. 1998 May;72(5):3827-36. doi: 10.1128/JVI.72.5.3827-3836.1998.
5
No requirement of HCV 5'NCR for HCV-like particles assembly in insect cells.
World J Gastroenterol. 2003 Oct;9(10):2226-31. doi: 10.3748/wjg.v9.i10.2226.
6
Construction of the Vero cell culture system that can produce infectious HCV particles.
Mol Biol Rep. 2009 Jan;36(1):111-20. doi: 10.1007/s11033-007-9158-3. Epub 2007 Oct 25.
8
Three-dimensional visualization of forming Hepatitis C virus-like particles by electron-tomography.
Virology. 2012 Sep 1;430(2):120-6. doi: 10.1016/j.virol.2012.05.001. Epub 2012 May 31.
10
NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly.
PLoS Pathog. 2011 Feb 10;7(2):e1001278. doi: 10.1371/journal.ppat.1001278.

引用本文的文献

2
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic.
Viruses. 2023 Aug 23;15(9):1786. doi: 10.3390/v15091786.
3
Platforms, advances, and technical challenges in virus-like particles-based vaccines.
Front Immunol. 2023 Feb 9;14:1123805. doi: 10.3389/fimmu.2023.1123805. eCollection 2023.
4
Production and immunogenicity of different prophylactic vaccines for hepatitis C virus (Review).
Exp Ther Med. 2022 May 30;24(1):474. doi: 10.3892/etm.2022.11401. eCollection 2022 Jul.
6
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines.
Vaccines (Basel). 2022 Feb 2;10(2):227. doi: 10.3390/vaccines10020227.
8
[Development approaches for vaccines against hepatitis C virus infections].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Feb;65(2):183-191. doi: 10.1007/s00103-021-03477-9. Epub 2022 Jan 11.
9
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.
J Nanobiotechnology. 2021 Feb 25;19(1):59. doi: 10.1186/s12951-021-00806-7.
10
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1.
Cell Chem Biol. 2020 Jul 16;27(7):780-792.e5. doi: 10.1016/j.chembiol.2020.04.006. Epub 2020 May 7.

本文引用的文献

1
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.
Science. 1997 Jul 25;277(5325):570-4. doi: 10.1126/science.277.5325.570.
2
The treatment of chronic viral hepatitis.
N Engl J Med. 1997 Jan 30;336(5):347-56. doi: 10.1056/NEJM199701303360507.
3
Vaccines to prevent viral hepatitis.
N Engl J Med. 1997 Jan 16;336(3):196-204. doi: 10.1056/NEJM199701163360307.
5
Unique features of internal initiation of hepatitis C virus RNA translation.
EMBO J. 1995 Dec 1;14(23):6010-20. doi: 10.1002/j.1460-2075.1995.tb00289.x.
6
Interaction between hepatitis C virus core protein and E1 envelope protein.
J Virol. 1996 Aug;70(8):5177-82. doi: 10.1128/JVI.70.8.5177-5182.1996.
8
Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7.
J Virol. 1996 Jun;70(6):4131-5. doi: 10.1128/JVI.70.6.4131-4135.1996.
10
Hepatitis C virus: detection of intracellular virus particles by electron microscopy.
Hepatology. 1996 Feb;23(2):205-9. doi: 10.1002/hep.510230202.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验